About the Study

About the Study

This study is designed to evaluate the efficacy of a single dose of 100 µg of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of depression symptoms.
This study is sponsored by Mind Medicine, Inc.

Length of Study:  Approximately 56 weeks: 30 day screening period, 12 week double-blind period, and a 40 week open-label-extension.

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 74 years old
• meet DSM-5 criteria for Major Depressive Disorder (MDD)
• are currently experience symptoms of depression
• can spend the day at our facility for an 8-hour dosing session (up to 12-hours if needed)

 

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. 

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.